HCV
Clinical trials for HCV explained in plain language.
Never miss a new study
Get alerted when new HCV trials appear
Sign up with your email to follow new studies for HCV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a short course of hepatitis c drugs before kidney transplant prevent infection?
Disease control Recruiting nowThis study looks at the best time to give hepatitis C medication to people without HCV who receive a kidney from an HCV-positive donor. One group starts the drug just before transplant and takes it for only 2 weeks; the other starts after transplant and takes it for 12 weeks. The…
Matched conditions: HCV
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowThis study tests a new device called MagIA H3S that can screen for HIV, hepatitis B, hepatitis C, and syphilis using a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab tests. If it …
Matched conditions: HCV
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Phone buddies and text alerts aim to slash HIV rates in rural appalachia
Prevention Recruiting nowThis study combines peer navigation (trained community members) with mobile health tools to help gay, bisexual, and transgender people in rural Appalachia access HIV, STI, and hepatitis C testing and prevention services. About 141 participants will be split into two groups: one g…
Matched conditions: HCV
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Baltimore study enlists peers to fight HIV and overdose among drug users
Prevention Recruiting nowThis pilot study tests whether a peer-driven program can help people who inject drugs in Baltimore reduce their risk of HIV, hepatitis C, and overdose. Researchers will identify high-risk injection settings and train peers to promote safer practices, like carrying naloxone and av…
Matched conditions: HCV
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Austrian study seeks to eliminate hepatitis by linking patients to care
Knowledge-focused Recruiting nowThis study in South-East Austria looks at past lab results to find people with hepatitis B, C, or D who may not know they have it. Researchers will invite these individuals to a clinic to discuss treatment options. The goal is to connect them to care and track how many get cured,…
Matched conditions: HCV
Sponsor: Vanessa Stadlbauer-Koellner, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gut check: new study probes how hepatitis drug changes your microbiome
Knowledge-focused Recruiting nowThis study looks at how the drug bulevirtide changes gut bacteria and bile acids in people with hepatitis delta (a serious liver infection). Researchers will follow 20 patients for 48 weeks, collecting stool and blood samples to see how these changes relate to liver health. The g…
Matched conditions: HCV
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC